THE AHEAD STUDY IS TESTING LECANEMAB AT THE STAGE OF PRECLINICAL ALZHEIMER’S DISEASE

SAN DIEGO, July 11, 2023 /PRNewswire/ — Alzheimer’s disease (AD) researchers increasingly believe that treating at the earliest possible stage may be key to helping combat the disease. Ongoing studies are now testing whether lecanemab can effectively delay or prevent the symptoms of…

Leave a Reply

Your email address will not be published. Required fields are marked *